Surgery – Miscellaneous – Methods
Reexamination Certificate
2006-11-28
2006-11-28
McDermott, Corrine (Department: 3738)
Surgery
Miscellaneous
Methods
C600S300000
Reexamination Certificate
active
07140371
ABSTRACT:
Skin topographical methods for quantifying pharmacodynamic parameters of a paralytic effect of a Clostridial toxin, such as abotulinumtoxin upon a muscle, such as a frontalis muscle. The methods are effective in determining the potency of a Clostridial toxin, and in comparing toxins. For example, wrinkle reduction effects caused by one or more neurotoxins may be monitored, and differences in effects correspond to differences of neurotoxins.
REFERENCES:
patent: 3689638 (1972-09-01), Piette
patent: 4758730 (1988-07-01), Bazin
patent: 4932936 (1990-06-01), Dykstra et al.
patent: 4997657 (1991-03-01), Horrobin
patent: 5183462 (1993-02-01), Borodic
patent: 5437291 (1995-08-01), Pasricha et al.
patent: 5512547 (1996-04-01), Johnson et al.
patent: 5670484 (1997-09-01), Binder
patent: 5714468 (1998-02-01), Binder
patent: 5766606 (1998-06-01), Brady
patent: 5989545 (1999-11-01), Foster et al.
patent: 6063768 (2000-05-01), First
patent: 6113915 (2000-09-01), Aoki et al.
patent: 6139845 (2000-10-01), Donovan
patent: 6143306 (2000-11-01), Donovan
patent: 6261572 (2001-07-01), Donovan
patent: 6265379 (2001-07-01), Donovan
patent: 6506399 (2003-01-01), Donovan
patent: 6688311 (2004-02-01), Hanin
patent: 6701171 (2004-03-01), Quistorff et al.
patent: 2002/0064536 (2002-05-01), Hunt
patent: 2003/0118598 (2003-06-01), Hunt
patent: 19852981 (2000-05-01), None
patent: WO9633273 (1996-10-01), None
patent: WO9807864 (1998-02-01), None
patent: WO9903483 (1999-01-01), None
patent: WO9917806 (1999-04-01), None
patent: WO0010598 (2000-03-01), None
patent: WO0015245 (2000-03-01), None
patent: WO0024419 (2000-05-01), None
patent: WO0057897 (2000-10-01), None
patent: WO0062746 (2000-10-01), None
patent: WO0074703 (2000-12-01), None
patent: WO0121213 (2000-12-01), None
Ascher et al, french translation of Botulinum Toxin in the Treatment of Frontoglabellar and Periorbital Wrinkles, Annales de Chirurgie Plastique et Esthetique, Feb. 1995, 40(1):67-76.
Guerrisis, Jorge et al., Local Injection into Mimetic Muscles of Botulinum Toxin A for the Treatment of Facial Lines, Annals of Plastic Surgery, vol. 39, No. 5, pp. 447-453, Nov. 1997.
Hamlin, Ja et al. Serial Neurophysiological Studies of Intramuscular Botulinum-A toxin in Humans. Muscle & Nerve, pp. 1385-1392, Dec. 1994.
Koman, La et al. Spasticity Associated with Cerebral Palsy in Children, Therapy in Practice, Pediatric Drugs, 2003.
Aoki, R et al. Preclinical update on BOTOX (botulinum toxin type A)-purified neurotoxin complex relative to other botulinum neurotoxin preparations. European Journal of Neurology, vol. 6 (Suppl 4): S3-S10, 1996.
Brach, Jennifer S et al. Measuring Fatigue Related to Facial Muscle Function, Arch. Phys. Med Reabil, vol. 76, pp. 905-908, Oct. 1995.
Carruthers, J et al. Treatment of Glabellar Frown Lines with C. Botulinum-A Exotoxin, J. Dermatol Surg. Oncol. vol. 18, No. 1, pp. 17-21, Jan. 1992.
Corcuff, P et al. Skin Relief and Agin, J. Society. Cosmet. Chem, vol. 34. pp. 177-190, Jul. 1983.
Dogweiler R. Botulinum Toxin type A causes diffuse and highly selective atrophy of rat prostate. Neurourol Urodyn, vol. 17, No. 4, p. 363, 1998.
Dressler D et al., Electromyographic Quantification of the Paralysing Effect of Botulinum Toxin in the Stemocleidomastoid Muscle. European Neurology, vol. 43, pp. 13-16, 2000.
Fauci, Anthony et al. Harrison's Principles of Internal Mediciine, 14th Edition, 1998 by McGraw Hill.
Fridlund, Alan et al. Guidelines for human electromyographic research. The Socieity for Psychophysiological Research, Inc. vol. 23, No. 5, pp. 567-589, 1986.
Grove, Gary et al. Objective Methods for Assessing Skin Surface Topography Noninvasively. Cutaneous Investigation in Health and Disease, by Marcel Dekker, Inc., Chapter One, pp. 1-32, 1989.
Grove, Gary et al. Skin replica analysis of photodamaged skin after therapy with tretinoin emollient cream. Journal of the American Academy of Dermatology. vol. 25, No. 2, Part I, pp. 231-237, Aug. 1991.
Heckman, Marc et al. Quantification of the efficacy of botulinum toxin type A by digital image analysis. Journal of American Academy of Dermatology, Oct. 2001, vol. 45, pp. 508-514, published online May 23, 2001.
Johnson Eric A. Biomedical aspects of Botulinum Toxin. J. Toxicol Toxin Reviews, vol. 18, No. 1, pp. 1-15, Abstract, 1999.
Leyden, James J. et al. Treatment of photodamaged facial skin with topical tretinoin. Journal of the American Academy of Dermatology, vol. 21, No. 3, Part 2, pp. 638-644, Sep. 1989.
Pennock, Jennifer D. et al. Relationship between muscle activity of the frontalis and the associated brow displacement. Plast. Reconstr. Surg. vol. 104, No. 6, pp. 1789-1797, Nov. 1999.
Senior, Ma. Botox and the management of pectoral spasm after subpectoral implant insertion. Plast. Reconstr. Surg. vol. 106, No. 1, pp. 224-225, July 2000.
Tassinary, Louis G. et al. A psychometric study of surface electrode placements for facial electromyographic recording: I. The Brow and Cheek Muscle Regions. Pyschophysiology, vol. 26, No. 1, pp. 1-16, Abstract, 1989.
Van Boxtel, A. et al. Amplitude and Bandwidth of the Frontalis Surface EMG: Effects of Electrode parameters. Pyschophysiology, vol. 21, No. 6, pp. 699-707, Abstract, 1984.
Vitti, Mathias et al. Electromyograhpic Investigation of Procerus and Frontalis Muscles. Electromyogr. Clin. Neurophysiol. vol. 16, pp. 227-236, 1976.
Guerrisis, Jo. Injection of botulinum toxin A into orbicularis oculi muscle for the treatment of crow's feet and the discussion thereof. Plastic and Reconstructive Surgery (United States), vol. 105, No. 6, pp. 2219-2228, May 2000.
Ascher, B et al. La Toxin Botulique Dans Le Traitement Des Rides Fronto-Glabellaires et de la Region Orbitaire. Annales de Chirurgui Plastique et Esthetique, vol. 40, No. 1, pp. 67-76, Feb. 1995.
Sloop, RR et al. Dose-response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A, Neurology, vol. 46, No. 5, pp. 1382-1386, May 1996.
Jacobi, U et al. In vivo determination of skin surface topography using an optical 3D device. Skin Res. Technol. vol. 10, No. 4, pp. 207-214, Nov. 2004.
Blitzer et al. Journal Abstract from the Archives of Otolaryngology-Head & Neck Surgery, vol. 123, No. 4, pp. 389-392, Apr. 1997.
Pribitkin et al. Journal Abstract from the Archives of Otolaryngology-Head & Neck Surgery, vol. 123, No. 4, pp. 321-326, Apr. 1997.
Brooks Gregory F.
Hanin Lisa D.
Allergan Inc.
Donovan Stephen
McDermott Corrine
Sweet Thomas J.
LandOfFree
Surface topography method for determining effects of a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Surface topography method for determining effects of a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Surface topography method for determining effects of a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3647730